Objectives: Bovine alkaline phosphatase (BALP) mediated interference is a potential issue in the Beckman Access unconjugated estriol (uE3) assay. As the uE3 assay is a component of second trimester maternal serum screening characterizing this interference is essential for delivering accurate trisomy 18 and trisomy 21 risks.

Design And Methods: Residual serum samples (n = 517) were measured by two different lots of uE3 assay. Scavenger BALP (sBALP) was added to all samples to remove potential BALP dependent interference and assessed using both lots of uE3 reagent.

Results: BALP mediated interference was observed in similar frequency in both lots of reagent (~3%), although the patterns of positive and negative interference differed between the lots. Pretreatment with sBALP improved lot-to-lot comparison. The presence of BALP related interference was not related to the concentration of endogenous human alkaline phosphatase. The use of polyethylene glycol and sBALP treatment appeared to mitigate BALP mediated interference equally well, and resulted in concordance in measured uE3 concentrations between reagent lots. Additionally, heterophile antibody interference was observed in two samples affected with BALP interference, and the heterophile antibody interference was resolved by both PEG and heterophile antibody blocking reagent treatment, but not sBALP treatment. While the maternal screen numeric risk for affected samples changed, the risk classification changed from a negative to positive screen in two samples.

Conclusions: Interference in the uE3 assay has the potential to affect maternal serum risk calculations in different reagent lots, and pretreatment of samples with scavenger BALP or PEG should be considered in cases of unexplained uE3 concentrations.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2020.11.007DOI Listing

Publication Analysis

Top Keywords

ue3 assay
20
alkaline phosphatase
12
interference
12
maternal serum
12
balp mediated
12
mediated interference
12
heterophile antibody
12
bovine alkaline
8
beckman access
8
access unconjugated
8

Similar Publications

Article Synopsis
  • The study looked at a protein called PAPP-A in pregnant women to see how it relates to a condition called preeclampsia.
  • It compared 65 women with preeclampsia to 45 healthy pregnant women, finding that those with preeclampsia had lower levels of PAPP-A and another hormone called uE3, but higher levels of a protein called AFP.
  • The results suggest that measuring PAPP-A and the other proteins could help doctors diagnose preeclampsia early and understand how serious it is.
View Article and Find Full Text PDF

Objective: To explore the association between the concentration of maternal serum biomarkers and the risk of fetal carrying chromosome copy number variants (CNVs).

Methods: Pregnant women identified as high risk in the second-trimester serological triple screening and underwent traditional amniotic fluid karyotype analysis, along with comparative genomic hybridization array (aCGH)/copy number variation sequencing (CNV-seq), were included in the study. We divided the concentration of serum biomarkers, free beta-human chorionic gonadotropin (fβ-hCG), alpha fetoprotein (AFP) and unconjugated estriol (uE3), into three levels: abnormally low, normal and abnormally high.

View Article and Find Full Text PDF

Association Analysis between Maternal Serum Biomarkers and Fetal Congenital Heart Disease.

Heart Surg Forum

October 2023

Department of Obstetrics and Gynecology, The First Affiliated Hospital of Fujian Medical University, 350005 Fuzhou, Fujian, China; Department of Obstetrics and Gynecology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, 350212 Fuzhou, Fujian, China.

Objective: To investigate the association of maternal serum biomarkers alpha fetal protein (AFP), β-human chorionic gonadotropin (HCG) and unconjugated estriol 3 (uE3) in the second trimester with fetal congenital heart disease (CHD) in low risk populations during the screening of Down's syndrome.

Methods: 109 cases diagnosed with fetal CHD in the second trimester by fetal echocardiography were enrolled as the CHD group. Pregnancy- and gestational-age matched 344 cases without fetal CHD were used as the control group.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to assess how vanishing twin (VT) affects maternal serum marker levels and nuchal translucency (NT) during pregnancy.
  • - Conducted as a secondary analysis of a larger study involving 6,793 pregnant women, the research found that women in the VT group had higher levels of alpha-fetoprotein (AFP) and inhibin A compared to those with normal singleton pregnancies.
  • - The findings suggest that VT should be factored into risk assessments during second-trimester serum screening tests due to its association with abnormal AFP levels.
View Article and Find Full Text PDF

Introduction: We aimed to investigate the effects of colchicine use on first and second trimester screening markers in pregnancies complicated with familial Mediterranean fever (FMF) and to evaluate the overall impact of these effects on perinatal outcomes.

Methods: A retrospective case-control study was conducted in pregnancies complicated with FMF using colchicine and healthy pregnancies as controls without any defined risk factors and medication use. Biochemical markers for the aneuploidy screening, including free ß-hCG and PAPP-A in the first trimester, and AFP, HCG, and unconjugated estriol (uE3) in the second trimester, were recorded, and MoM levels of these markers were compared between the FMF and control groups.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!